News

AI Echo For Aortic Stenosis Severity Assessment

AI Echo for Aortic Stenosis Severity

By Us2.ai / 26 June, 2023 / Comments Off on AI Echo for Aortic Stenosis Severity

Aortic stenosis (AoS) is a common form of valvular heart disease present in 12% of the population aged above 75. If left untreated, 1/4 of those with severe symptomatic AoS will die from this condition within 2 years. Echo is the primary imaging modality used to diagnose AoS, but the necessary imaging is time consuming…

Read More
AI For Echocardiography

The Future of AI Guided Echo

By Us2.ai / 21 June, 2023 / Comments Off on The Future of AI Guided Echo

Join the virtual echo rounds deep dive with Us2.ai for detailed examples real time processing of complete echo reports and see why the future of AI for echocardiograms is already here today.

Read More
AI Echo Copilot

AI echo copilot – the future of echocardiography

By Us2.ai / 27 May, 2023 / Comments Off on AI echo copilot – the future of echocardiography

Us2.connect turns any ultrasound device into your AI echo copilot. From CARTs to mobile devices, any echo machine can now have 100% automated reporting with disease detection and editable measurements, all generated in realtime as you scan. See the AI echo copilot video There is constant demand for highly trained sonographers and cardiologists to examine…

Read More
AI Echocardiogram GE Vivid E95

AI echocardiogram reports fully automated from a GE Vivid E95

By Us2.ai / 26 May, 2023 / Comments Off on AI echocardiogram reports fully automated from a GE Vivid E95

Fully automated echo reporting and disease detection in realtime with the GE Vivid E95. The future of AI for ultrasound is here today!

Read More
AI Heart Failure Diagnosis

AI heart failure diagnosis at home with cardiac ultrasound

By Us2.ai / 21 May, 2023 / Comments Off on AI heart failure diagnosis at home with cardiac ultrasound

We have an increasing number of patients with diabetes, hypertension and chronic kidney disease who know about their chronic disease but don’t know whether they have heart failure or not.  We need to have a way to determine those patients who have, or who are at risk of having heart failure, without necessarily needing to see…

Read More
AI Echo Mobile Heart Failure

Biomarkers and AI for the transformation of heart failure diagnosis

By Us2.ai / 20 May, 2023 / Comments Off on Biomarkers and AI for the transformation of heart failure diagnosis

The ESC Heart Failure Guidelines recommend measurement of plasma NT-proBNP concentration as an initial step, and echocardiography as a necessary tool to confirm HF diagnosis, as well as to distinguish between types of HF. Nt-proBNP biomarker testing and echocardiography delivered in primary care and community settings could potentially expand access to screening and enable earlier…

Read More
AI Echo for Heart Failure

Heart Failure 2023 – visit Us2.ai together with Roche

By Us2.ai / 20 May, 2023 / Comments Off on Heart Failure 2023 – visit Us2.ai together with Roche

Heart failure affects 64 million people worldwide and many cases remain undetected and/or untreated despite available evidence-based therapies. AI can help tackle this problem with 100% automated disease detection. Join us in Prague at Heart Failure 2023 in the Roche booth for live demonstrations of AI automated echo for the detection of heart failure. Automation…

Read More
AI Echo For Cardiac Amyloidosis

AI Echo for Cardiac Amyloidosis

By Us2.ai / 16 May, 2023 / Comments Off on AI Echo for Cardiac Amyloidosis

Transthyretin (ATTR) amyloidosis is emerging as an under recognized form of heart failure especially in the elderly.  The aim of the study was to assess the ability of Us2.ai to assess prognosis, in this patient population, at the University College London National Amyloidosis Centre, the largest center worldwide for cardiac amylodosis. “With Us2.ai software, in a little more than…

Read More
AI Echo For Mitral Regurgitation

AI Echo for Mitral Regurgitation Severity Grading

By Us2.ai / 16 May, 2023 / Comments Off on AI Echo for Mitral Regurgitation Severity Grading

In the US and Europe, Mitral Regurgitation (MR) is the most common valvular heart disease.  It is very difficult to grade MR, but extremely important because the more severe the MR is, the worse the prognosis for patients. Unfortunately, using echocardiograms and other modalities to grade MR they is very cumbersome, lengthy and inaccurate.  AI could…

Read More
AI Strain Echocardiography

AI Strain Echocardiography

By Us2.ai / 15 May, 2023 / Comments Off on AI Strain Echocardiography

Strain imaging is currently the most sensitive parameter reflecting myocardial deformation and systolic left ventricular function.  Reduced left ventricular global longitudinal strain (GLS) predicts adverse events, as well as helps diagnose myocardial diseases and monitor sub-clinical myocardial disease progression. We analyzed myocardial global longitudinal strain in three different cohorts. Fully automated measurements of GLS and…

Read More